The energetics of Huntington's disease

被引:190
作者
Browne, SE [1 ]
Beal, MF [1 ]
机构
[1] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA
关键词
Huntington's disease; Huntingtin mitochondria; energy metabolism; glucose utilization; genetic models;
D O I
10.1023/B:NERE.0000014824.04728.dd
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is a hereditary neurodegenerative disorder that gradually robs sufferers of the ability to control movements and induces psychological and cognitive impairments. This devastating, lethal disease is one of several neurological disorders caused by trinucleotide expansions in affected genes, including spinocerebellar ataxias, dentatorubralpallidoluysian atrophy, and spinal bulbar muscular atrophy. HD symptoms are associated with region-specific neuronal loss within the central nervous system, but to date the mechanism of this selective cell death remains unknown. Strong evidence from studies in humans and animal models suggests the involvement of energy metabolism defects, which may contribute to excitotoxic processes, oxidative dmage, and altered gene regulation. The development of transgenic mouse models expressing the human HD mutation has provided novel opportunities to explore events underlying selective neuronal death in HD, which has hitherto been impossible in humans. Here we discuss how animal models are redefining the role of energy metabolism in HD etiology.
引用
收藏
页码:531 / 546
页数:16
相关论文
共 144 条
[1]   ABNORMALITIES OF STRIATAL PROJECTION NEURONS AND N-METHYL-D-ASPARTATE RECEPTORS IN PRESYMPTOMATIC HUNTINGTONS-DISEASE [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB ;
HANDELIN, B ;
BALFOUR, R ;
ANDERSON, KD ;
MARKEL, DS ;
TOURTELLOTTE, WW ;
REINER, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (18) :1293-1298
[2]   ALTERNATIVE EXCITOTOXIC HYPOTHESES [J].
ALBIN, RL ;
GREENAMYRE, JT .
NEUROLOGY, 1992, 42 (04) :733-738
[3]   STRIATAL AND NIGRAL NEURON SUBPOPULATIONS IN RIGID HUNTINGTONS-DISEASE - IMPLICATIONS FOR THE FUNCTIONAL-ANATOMY OF CHOREA AND RIGIDITY-AKINESIA [J].
ALBIN, RL ;
REINER, A ;
ANDERSON, KD ;
PENNEY, JB ;
YOUNG, AB .
ANNALS OF NEUROLOGY, 1990, 27 (04) :357-365
[4]   Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease [J].
Andreassen, OA ;
Dedeoglu, A ;
Ferrante, RJ ;
Jenkins, BG ;
Ferrante, KL ;
Thomas, M ;
Friedlich, A ;
Browne, SE ;
Schilling, G ;
Borchelt, DR ;
Hersch, SM ;
Ross, CA ;
Beal, MF .
NEUROBIOLOGY OF DISEASE, 2001, 8 (03) :479-491
[5]   Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease [J].
Andreassen, OA ;
Ferrante, RJ ;
Huang, HM ;
Dedeoglu, A ;
Park, L ;
Ferrante, KL ;
Kwon, J ;
Borchelt, DR ;
Ross, CA ;
Gibson, GE ;
Beal, MF .
ANNALS OF NEUROLOGY, 2001, 50 (01) :112-117
[6]   Huntington's disease progression PET and clinical observations [J].
Andrews, TC ;
Weeks, RA ;
Turjanski, N ;
Gunn, RN ;
Watkins, LHA ;
Sahakian, B ;
Hodges, JR ;
Rosser, AE ;
Wood, NW ;
Brooks, DJ .
BRAIN, 1999, 122 :2353-2363
[7]   Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET [J].
Andrews, TC ;
Brooks, DJ .
MOLECULAR MEDICINE TODAY, 1998, 4 (12) :532-539
[8]   Striatal glucose metabolism and dopamine D-2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease [J].
Antonini, A ;
Leenders, KL ;
Spiegel, R ;
Meier, D ;
Vontobel, P ;
WeigellWeber, M ;
SanchezPernaute, R ;
deYebenez, JG ;
Boesiger, P ;
Weindl, A ;
Maguire, RP .
BRAIN, 1996, 119 :2085-2095
[9]   Complex I defect in muscle from patients with Huntington's disease [J].
Arenas, J ;
Campos, Y ;
Ribacoba, R ;
Martín, MA ;
Rubio, JC ;
Ablanedo, P ;
Cabello, A .
ANNALS OF NEUROLOGY, 1998, 43 (03) :397-400
[10]   Are there multiple pathways in the pathogenesis of Huntington's disease? [J].
Aronin, N ;
Kim, M ;
Laforet, G ;
DiFiglia, M .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) :995-1003